Anal Canal Squamous Cell Carcinoma
5 clinical trials · Condition
◉ Watch Anal Canal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer (NCT04499352) | Boehringer Ingelheim | 2020-09-14 |
| Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study (NCT04166318) | ECOG-ACRIN Cancer Research Group | 2020-01-02 |
| Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial (NCT03690921) | M.D. Anderson Cancer Center | 2018-11-08 |
| Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy (NCT03712566) | University Health Network, Toronto | 2018-11-06 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer (NCT02314169) | National Cancer Institute (NCI) | 2015-05-13 |
Track Anal Canal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.